$125 Million is the total value of Daniel Devine & Co's 48 reported holdings in Q2 2018. The portfolio turnover from Q1 2018 to Q2 2018 was 25.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| JNJ | Sell | Johnson & Johnson | $3,593,000 | -7.9% | 29,607 | -2.8% | 2.87% | -9.4% |
| ABBV | Sell | Abbvie Inc | $2,490,000 | -13.4% | 26,880 | -11.5% | 1.99% | -14.8% |
| CVX | Sell | Chevron Corporation | $2,429,000 | +0.4% | 19,214 | -9.4% | 1.94% | -1.2% |
| HON | Sell | Honeywell Int'l | $2,068,000 | -7.4% | 14,355 | -7.1% | 1.65% | -8.9% |
| PFE | Sell | Pfizer Inc | $1,976,000 | -6.0% | 54,459 | -8.1% | 1.58% | -7.5% |
| GOOGL | Sell | Alphabet (Google) Inc CL A vot | $1,902,000 | +7.9% | 1,684 | -0.9% | 1.52% | +6.2% |
| Sell | Samsung Electronics - GDRspon adr | $1,578,000 | -14.8% | 1,510 | -6.2% | 1.26% | -16.2% | |
| NVS | Sell | Novartis ADRspon adr | $1,394,000 | -20.3% | 18,450 | -14.8% | 1.11% | -21.6% |
| SBUX | Sell | Starbucks Corp | $1,340,000 | -21.7% | 27,425 | -7.3% | 1.07% | -23.0% |
| RDSB | Sell | Royal Dutch Shell PLC-ADR B | $1,259,000 | -13.5% | 17,325 | -22.0% | 1.01% | -15.0% |
| AZN | Sell | AstraZeneca PLC - Spons ADRspon adr | $506,000 | -61.3% | 14,400 | -61.5% | 0.40% | -62.0% |
| MO | Sell | Altria Group Inc. | $244,000 | -54.5% | 4,300 | -50.0% | 0.20% | -55.2% |
| BKNG | Exit | Booking Holdings Inc | $0 | – | -100 | -100.0% | -0.17% | – |
| INTC | Exit | Intel Corp | $0 | – | -4,050 | -100.0% | -0.17% | – |
| HBI | Exit | Hanesbrands Inc | $0 | – | -44,570 | -100.0% | -0.67% | – |
| TGT | Exit | Target Corporatiion | $0 | – | -19,210 | -100.0% | -1.08% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-07-18
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| SPDR S&P 500 | 15 | Q2 2018 | 24.0% |
| Powershares QQQ Trust | 15 | Q2 2018 | 13.0% |
| SPDR S&P Midcap 400 | 15 | Q2 2018 | 12.1% |
| Apple Inc | 15 | Q2 2018 | 6.0% |
| Johnson & Johnson | 15 | Q2 2018 | 4.0% |
| IShares MSCI Emerg Mkt | 15 | Q2 2018 | 2.6% |
| Chevron Corporation | 15 | Q2 2018 | 2.6% |
| Visa Inc Cl A | 15 | Q2 2018 | 2.1% |
| Abbvie Inc | 15 | Q2 2018 | 2.3% |
| Select Sector SPDR Industrial | 15 | Q2 2018 | 3.0% |
View Daniel Devine & Co's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2018-07-18 |
| 13F-HR | 2018-04-25 |
| 13F-HR | 2018-01-24 |
| 13F-HR | 2017-11-17 |
| 13F-HR | 2017-07-20 |
| 13F-HR | 2017-04-27 |
| 13F-HR | 2017-01-19 |
| 13F-HR | 2016-10-21 |
| 13F-HR | 2016-07-29 |
| 13F-HR | 2016-04-13 |
View Daniel Devine & Co's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.